Amedeo's Top 20

Amedeo Smart

Independent Medical Education

01 April 2024

Multidisciplinary Journal Club

  1. Slamon D, Lipatov O, Nowecki Z, McAndrew N, et al.
    Ribociclib plus Endocrine Therapy in Early Breast Cancer.
    N Engl J Med 2024;390:1080-1091.

  1. Krishnan S, Chaisson RE.
    US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
    Clin Infect Dis 2024;78:514-517.

  2. Khrom M, Long M, Dube S, Robbins L, et al.
    Comprehensive association analyses of extraintestinal manifestations in inflammatory bowel disease.
    Gastroenterology 2024.

  3. Penna GC, Bensenor IM, Bianco AC, Ettleson MD, et al.
    Thyroid hormone homeostasis in levothyroxine-treated patients: Findings from ELSA-Brasil.
    J Clin Endocrinol Metab 2024.

  4. Patel SM, Braunwald E, Steffel J, Boriani G, et al.
    Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58 464 Patients With Atr
    Circulation 2024.

  1. Del Bene VA, Martin RC, Brinkerhoff SA, Olson JW, et al.
    Differential Cognitive Effects of Unilateral Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease.
    Ann Neurol 2024.

  2. Merlijn T, Swart KMA, Niemeijer C, van der Horst HE, et al.
    The yield of routine laboratory examination in osteoporosis evaluation in primary care.
    Osteoporos Int 2024.

  3. Goldacre R.
    Risk of multiple sclerosis in individuals with infectious mononucleosis: a national population-based cohort study using hospital records in England, 2003-2023.
    Mult Scler 2024.

  4. Zhao Y, Lai Y, Konijnenberg H, Huerta JM, et al.
    Association of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort.
    Neurology 2024;102:e209201.

  5. Lee TS, Li I, Peric B, Saw RPM, et al.
    Leg Lymphoedema After Inguinal and Ilio-Inguinal Lymphadenectomy for Melanoma: Results from a Prospective, Randomised Trial.
    Ann Surg Oncol 2024.

  1. Morrow DA, Velazquez EJ, Desai AS, DeVore AD, et al.
    Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure.
    J Am Coll Cardiol 2024;83:1123-1132.

  2. Williams-Farrelly MM, Schroeder MW, Li C, Perkins AJ, et al.
    Loneliness in older primary care patients and its relationship to physical and mental health-related quality of life.
    J Am Geriatr Soc 2024;72:811-821.

  3. Lamas Perez R, Millan-Vazquez M, Gonzalez-Oria C.
    Efficacy and safety of galcanezumab as chronic cluster headache preventive treatment under real world conditions: Observational prospective study.
    Cephalalgia 2024;44:333102423122618.

  4. Marotta V, Rocco D, Crocco A, Deiana MG, et al.
    Survival predictors of radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the real-life.
    J Clin Endocrinol Metab 2024.

  5. Maier CL, Brohi K, Curry N, Juffermans NP, et al.
    Contemporary management of major haemorrhage in critical care.
    Intensive Care Med 2024;50:319-331.

  1. Hu FH, Tang XL, Ge MW, Jia YJ, et al.
    Mortality of children and adolescents co-infected with tuberculosis and HIV: a systematic review and meta-analysis.
    AIDS 2024.

  2. Bassetti M, Giacobbe DR, Agvald-Ohman C, Akova M, et al.
    Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.
    Intensive Care Med 2024.

  3. Fujita N, Ono Y, Hashimoto K, Kawamura Y, et al.
    Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report.
    Osteoporos Int 2024;35:733-736.

  4. Cai Y, Shi D, Lan G, Chen L, et al.
    Association of beta-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia.
    Neurology 2024;102:e209205.

  5. Peyrin-Biroulet L, Bossuyt P, Bettenworth D, Loftus EV Jr, et al.
    Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.
    Dig Dis Sci 2024.


more..

Privacy Policy